mail2

Press

Chugai SAkuraSky Phase III Results

October 23, 2018 | Beverly Hills, CA — Chugai Pharmaceutical Co. announced positive results from one of its phase III clinical trials of satralizumab (SA237),…

Alexion Prevent Phase 3 Results

September 25, 2018 | Beverly Hills, CA — The Guthy-Jackson Charitable Foundation (GJCF) congratulates Alexion Pharmaceuticals on their announcement of positive results from the PREVENT…